Zuqiang Liu

Also affiliated with Fudan University, Hubei Water Resources Research Institute, Jiangsu Changjiang Electronics Technology (China), Hubei Provincial Water Resources and Hydropower Planning Survey and Design Institute, Zhongshan Hospital, South China Institute of Collaborative Innovation, Hubei University of Technology

Immunology and MicrobiologyBiochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Oncolytic vaccinia virus delivering tethered IL-12 enhances antitumor effects with improved safety”.

Oncolytic vaccinia virus delivering tethered IL-12 enhances antitumor effects with improved safety

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-000710

N/A

0DataRank · unranked

79 citations

Haiyan Wang, Jinghua Ren, Weilin Liu, Lingjuan Chen, Hongqi Chen +8 more

In Situ Therapeutic Cancer Vaccination with an Oncolytic Virus Expressing Membrane-Tethered IL-2

Molecular Therapy — Oncolytics(2020)10.1016/j.omto.2020.04.006

N/A

0DataRank · unranked

38 citations

Enyong Dai, Zuqiang Liu, Congrong Ma, Zong Sheng Guo, David L. Bartlett +1 more

IL-36γ-armed oncolytic virus exerts superior efficacy through induction of potent adaptive antitumor immunity

Cancer Immunology Immunotherapy(2021)10.1007/s00262-021-02860-4

N/A

0DataRank · unranked

26 citations

Esther Giehl, Chao Feng, Mathilde Feist, Hongqi Chen, Enyong Dai +7 more

In Vivo Priming of Peritoneal Tumor-Reactive Lymphocytes With a Potent Oncolytic Virus for Adoptive Cell Therapy

Frontiers in Immunology(2021)10.3389/fimmu.2021.610042

N/A

0DataRank · unranked

11 citations

Hiromichi Kosaka, Zuqiang Liu, Mathilde Feist, Udai S. Kammula, Michael T. Lotze +4 more

Specific inhibitor to KRASG12C induces tumor-specific immunity and synergizes with oncolytic virus for enhanced cancer immunotherapy

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-010514

N/A

0DataRank · unranked

4 citations

Hongqi Chen, Chao Feng, Lingjuan Chen, Congrong Ma, Zuqiang Liu +6 more

The Interleukin-8-CXCR1/2 Axis as a Therapeutic Target in Peritoneal Carcinomatosis

Current Oncology(2025)10.3390/curroncol32090496

N/A

0DataRank · unranked

4 citations

Neda Dadgar, Zuqiang Liu, Yong Fan, Kunhong Xiao, Ali H. Zaidi +5 more